A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

ClinicalTrials.gov ID: NCT05873686

Public ClinicalTrials.gov record NCT05873686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 16, 2026, 3:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT05873686
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Nuvectis Pharma, Inc.; Industry
Enrollment: 140 participants

Conditions and interventions

Conditions

Interventions

NXP900 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 25, 2023
Primary completion: Feb 28, 2027
Completion: Jun 30, 2027
Last update posted: Mar 2, 2026

2023 – 2027

United States locations

U.S. sites: 10
U.S. states: 8
U.S. cities: 9

Facility	City	State	ZIP	Site status
Mayo Clinic	Phoenix	Arizona	85054	Recruiting
Sarah Cannon Research Institute at HealthONE	Denver	Colorado	80218	Recruiting
Mayo Clinic	Jacksonville	Florida	32224	Recruiting
University of Chicago	Chicago	Illinois	60637	Recruiting
Mayo Clinic Rochester	Rochester	Minnesota	55905	Recruiting
Oregon Health and Science University	Portland	Oregon	97239	Recruiting
The University of Texas MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
NEXT Oncology Houston	Houston	Texas	77054	Recruiting
NEXT Oncology Dallas	Irving	Texas	75039	Recruiting
NEXT Oncology Virginia	Fairfax	Virginia	22031	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05873686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 2, 2026 · Synced May 16, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05873686 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →